Prakhar Agrawal

Stock Analyst at Cantor Fitzgerald

(0)
# 4250
Out of 5,269 analysts
64
Total ratings
21.74%
Success rate
-11.79%
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
TVTX Travere Therapeutics
Reiterates: Overweight
n/a
n/a n/a 3 Apr 23, 2025
ACRS Aclaris Therapeutics
Reiterates: Overweight
n/a
n/a n/a 1 Mar 18, 2025
MTSR Metsera
Initiates Coverage On: Overweight
n/a
n/a n/a 1 Feb 25, 2025
KROS Keros Therapeutics
Downgrades: Neutral
n/a
n/a n/a 3 Jan 21, 2025
ORIC ORIC Pharmaceuticals
Reiterates: Overweight
n/a
n/a n/a 6 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
n/a
n/a n/a 1 Jan 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
10
n/a n/a 1 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 4 Nov 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
65 65
25.91 150.87% 12 Sep 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 10 Sep 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 5 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Feb 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 15
n/a n/a 2 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
58 48
n/a n/a 2 Jun 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
24
43.86 -45.28% 2 Apr 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
3 1
n/a n/a 1 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
450
2.38 18807.56% 1 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
21
n/a n/a 2 Jun 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
390
n/a n/a 1 Sep 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
n/a n/a 1 May 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
n/a n/a 1 Mar 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
0.44 3081.82% 1 Mar 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
6
n/a n/a 1 Mar 4, 2020